CTLA4 and lung cancer: For the first time, however, the results indicate that a combination of WBIs with blockade of the immune checkpoints such as CTLA-4 and PD-1, especially when the two had been inactivated together, also potently inhibited the growth of lung cancer cells in vivo and their clonogenic potential in vitro.